Ruite successfully passed the 2018 high-tech enterprise certification

Recently, good news came from the Department of Science and Technology of Guangdong Province. According to the relevant provisions of the "Management Measures for the Recognition of High tech Enterprises" and the "Guidelines for the Management of High tech Enterprise Recognition", after strict review by the Office of the National High tech Enterprise Recognition Management Leading Group, the Guangdong Provincial Department of Science and Technology, the Guangdong Provincial Department of Finance, the Guangdong Provincial State Taxation Bureau, the Guangdong Provincial Local Taxation Bureau and other relevant departments, our company successfully passed the second batch of high-tech enterprise recognition in Guangdong Province at the end of November 2018.

Enterprises recognized through this certification will not only enjoy the honorary title of "National High tech Enterprise", but also enjoy corresponding preferential policies in terms of taxation and other aspects of the country.

The achievement of this honor is not only a great affirmation of Ruite Biotechnology's recent achievements, but also a powerful impetus for the company's future development. The company will continue to increase its investment in research and development, continuously innovate in technology and management, and bring better products to the market, providing customers with higher quality solutions.

The technical renovation project has passed the expert group's acceptance smoothly

In June 2017, Guangzhou Ruite Biotechnology Co., Ltd.'s "Serum Batch Filling Production Line Technical Transformation Project" obtained the record of Guangdong Province Industrial and Information Port Technical Transformation Project. The project implementation period is from May 1, 2017 to December 31, 2017, with a planned total investment of 12 million yuan

The project strictly followed the expected plan and completed various indicators such as site renovation, equipment updates, system improvement, and qualification certification on schedule. A total of 36 new production equipment and testing instruments were added, and the capacity of the serum mixing tank increased from 500 liters to 3000 liters. The production volume of serum per batch increased by 6 times, and the filling speed increased from 5 bottles/minute to 20 bottles/minute. The stability of serum filling speed and volume was significantly improved, and the difference between batches was greatly reduced. The average annual production capacity of serum reached 100000 liters.

This project has accelerated the process of rapid development of the enterprise with a new look, and is an important milestone in the development history of Ruite Biotechnology.       

The project has also been approved as a provincial-level special fund for promoting economic development (for enterprise technological transformation purposes) in Guangdong Province in 2018, and has received a new round of policy support funds of 1.01 million yuan for enterprise technological transformation.

Conclusion: In the past two years, with the deepening of research and development projects and the continuous improvement of production quality systems, the technological level of enterprises has entered the leading ranks in China, and the product quality of animal blood products has greatly improved. As a result, Ruite Biotechnology has successfully entered the qualified supplier list of many well-known vaccine and diagnostic reagent production enterprises in China, and has achieved remarkable results in all aspects. At the end of 2018, Ruite Biotechnology sincerely thanks all new and old customers for their love and support. We promise to serve our customers with more enthusiasm and achieve the social value that our enterprise should have. Thank you 2018, 2019. I still love you!

Ruite Biotechnology - Your Trusted Partner!